Treatment of type 2 diabetes aims to uphold glycaemic control as beta cell function declines by escalating drug treatment from monotherapy to combined therapy. Many patients eventually require insulin. NICE guidelines acclaim isophane insulin as the insulin of the first choice, though many clinicians recommend a long-acting insulin analog.
Lupin has organized an interactive panel discussion on 7th July 2019 from 10.30 AM onwards. In this panel discussion, renowned international authorities will share their viewpoints on "Insulin Regime." We invite you to submit your questions which will be answered by the experts at the end of the session. PP-HM-IN-0055
